Skip to main content
SpringerLink
Log in
Book cover

Biothèrapies en rhumatologie pp 147–159Cite as

Biothérapies en développement dans l’arthrose

  • Chapter

  • 254 Accesses

Résumé

L’arthrose est de loin la plus fréquente des affections rhumatologiques. Elle affecte, audelà de 55 ans, plus de 50 % de la population. Il ne s’agit pas seulement d’une maladie du cartilage. Il existe en effet une inflammation précoce de la membrane synoviale, un renouvellement accéléré de l’os sous-chondral, mais également des modifi cations des structures para-articulaires qui jouent un role important dans l’évolution de la maladie.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Zhang W, Moskowitz RW, Nuki G et al. (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16:137–62

    Article  PubMed  CAS  Google Scholar 

  2. Pelletier JP, Martel-Pelletier J, Abramson SE (2001) Review: Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44:1237–47

    Article  PubMed  CAS  Google Scholar 

  3. Chevalier X (1998) Physiopathogenesis of osteoarthritis. The osteoarthritic cartilage. Presse Med 27: 81–7

    PubMed  CAS  Google Scholar 

  4. Benito MJ, Veale D, Fitzgerald O et al. (2002) Synovial tissue from patients with early osteoarthritis exhibits prominent features of inflammation. Arthritis Rheum 46(Suppl 9) S252:604

    Google Scholar 

  5. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. (2001) Synovitis predicts the arthroscopic progression of medial tibiofemoral knee osteoarthritis. Arthritis Rheum 44 Suppl 9: 952

    Google Scholar 

  6. Goldring Sr, Goldring MB (2004) The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Rel Res (427 Suppl): S27–36

    Article  Google Scholar 

  7. Chevalier X (1997) Up-regulation of enzymatic activity by interleukin-1 in osteoarthritis. Biomedicine Pharmacotherapy 51: 58–62

    Article  PubMed  CAS  Google Scholar 

  8. Caron IP, Fernandes JC, Martel-Pelletier J et al. (1996) Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum 39:1535–44

    Article  PubMed  CAS  Google Scholar 

  9. Bloom AB, van Lent PL, Holthuysen AE et al. (2004) Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 12: 627–35

    Article  Google Scholar 

  10. Bondenson I (2008) The role of activated synovial macrophages in osteoarthritis. Osteoarthritis Cartilage 16(Suppl 4) S8:1–24

    Google Scholar 

  11. Sachs D, Cunha FQ, Poole S et al. (2002) Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain 96:89–97

    Article  PubMed  CAS  Google Scholar 

  12. Chevalier X, Giraudeau B, Conrozier T et al. (2005) Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. I Rheumatol 32:1317–23

    Google Scholar 

  13. Chevalier X, Goupille P, Beaulieu AD et al. (2009) Intra-Articular Injection of Anakinra (r-met-huIL-1ra) in Osteoarthritis of the Knee: A Multicenter, Randomized, Double-blind, Placebo-controlled Study. Arthritis Rheum 61: 344–52

    Article  PubMed  CAS  Google Scholar 

  14. Loeuille D, Chary-Valckeneare I, Goebel G et al. (2005) MRI evaluation of the synovial membrane after single intra-articular injection of Anakinra in 7 patients with osteoarthritis of the knee suggests anti-inflammatory effect. Arthritis Rheum 52(Suppl 9): S70: 94

    Google Scholar 

  15. Cohen S, Proudman S, Kivitz A et al. (2007) Results of a randomised controlled trial of AMC 108 (a fuUy monoclonal human antibody to IL1R type 1) in patients with osteoarthritis of the knee. Arthritis Rheum 56(Suppl 9): 1684

    Google Scholar 

  16. Grunke M, Schulze-Koops H (2006) Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis 65(4): 555–6

    Article  PubMed  CAS  Google Scholar 

  17. Avouac J, Marini-Portugal A, Chevalier X (2004) A propos d’un cas d’arthrose digitale érosive: réponse spectaculaire aux anti-TNF alpha. Revue Rhum 71: Ma 158

    Google Scholar 

  18. Magnano MD, Chakravarty EF, Broudy C et al. (2007) A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol 34:1323–7

    PubMed  CAS  Google Scholar 

  19. Güler-Yüksel M, Kloppenburg M, AUaart CF et al. (2008) Infliximab might be protective against progressive interphalangeal osteoarthritis. Ann Rheum Dis 67(suppl II): 630: AB0714

    Google Scholar 

  20. Verbruggen G, Wittoek R, Vander C et al. (2009) Preliminary results of a phase II placebo controlled trail with adalimumab in erosive hand osteoarthritis: predictors of erosions and the potential effect of adalimumab in specific sub groups. Arthritis Rheum 60(Suppl 10): 856

    Google Scholar 

  21. Pelletier IP, Caron IP, Evans C, et al. (1997) 1n vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 40:1012–9

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. X. Chevalier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Richette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Compaore
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Chevalier, X., Richette, P., Compaore, C. (2011). Biothérapies en développement dans l’arthrose. In: Biothèrapies en rhumatologie. Springer, Paris. https://doi.org/10.1007/978-2-8178-0124-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0124-7_11

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0123-0

  • Online ISBN: 978-2-8178-0124-7

Publish with us

Policies and ethics

Search

Navigation